PPT-SUPPLEMENTARY FIGURES Figure S1

Figure S2 A B C D Figure S3 A B C D Figure S4 Figure S5 Figure S6 Figure S7 Figure S8 Supporting information 2 Original western blots Figure S9 Original western blots showing the concentrationdependent expression of CDK 4 6 Cyclin A2 and Vinculin upon treatment with MEP PAL on PC3 and . Supplementary Figure 2.YFP is appropriately expressed in the Sox10-expressing cells and their derivatives in Sox10::iCreERtransgenics. (A-B) YFP immunostaining of E12.5 pression was detected in DRG, n Supplementary Fig. 1. . Effect of G. a. s on the phosphorylation of ATM following . g. -ray irradiation in H1299 lung . cancer cells. . H1299 lung cancer cells were transfected . with . HA-tagged wild type G. Supplementary Figure . 2A:. . T-wave morphology changes upon stand-up test in LQTS . patients according to genotype. . Leads. – II, III, aVF. . Supplementary Figure . 2B:. . T-wave morphology changes upon stand-up test in LQTS patients according to . . . Somatic mutation spectrum. # Substitutions. # Substitutions per Mb. b. c. a. # Substitutions per Mb. Repeats. Pseudogenes. Whole genome. Splice sites. Non-coding RNA. Intron. Promoter. 5’ UTR. 3’ UTR. 3 Provenance One document describing the provenance of this figure is available This is a handwritten note in ink on lined paper that was provided to one artefacts AM 8891- 8903 from Malaita in the Sections Section 1 Formatting Figures within the Thesis or Dissertation p 2Information in this manual has been modified fromx0000x0000Updated by GC SST Summer 20212Section 1 Formatting Figures within YIV-906. (500mg/kg . p.o.. bid . x7. days) plus different dose of anti-PD1 . (70ug or 200ug/mice . i.p. . once) . against . Hepa. 1-6 in vivo.. Tumor size at the beginning were about . 270mm. 3. Reverse primer 5’ – 3’. (bp). Aggrecan (ACAN). XM_008251722.2. CAGGTCCTGTGCTGAAGAGC. CACAGTACTCGCCAGTGTGG. 101. SRY-box9 (SOX9). XM_008271763.2. GAAGCTCTGGAGACTGCTGAA. CCCATTCTTCACCGACTTCCT. 136. Analysis . of the CDK4/6 Cell-Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib . Michael . J. Böhm. 1. , Ralf Marienfeld. 1. , Daniela Jäger. 1. , Kevin Mellert. PCR amplification of . Sub1 . QTL controlling submergence tolerance using Sub1-A203 marker in . BC1F1 progenies . L. Positive parent. Negative parent. MSS-8. MSS-9. MSS-28. MSS-31. MSS-37. MSS-52. MSS-76. E. F. A. C. D. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. mJ. /cm. 2. was range of UV irradiation.. Supplementary data . Figure S2. Total phenolic and flavonoid contents of DW extract of . Nypa. . fruticans. . (NFD) and 100% . EtOH. extract of . Nypa. . Consort flow chart summarizing the number of patients screened, enrolled, treated and followed on the study. *one patient was re-assessed for eligibility at recurrence and re-enrolled on the study. Created with BioRender.com.. PsaM. proteins. Blue mark indicate conservation of amino acids below 90%.. Supplementary Figure 2. . (A) Phylogenetic tree of . PsaM. genes showing five clusters (mentioned as 1, 2, 3, 4, and 5). (B).